Purple Biotech (PPBT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.50
• Market Cap: $6.77M
• EPS: $-45.90
• 52-Week High: $3.05
• 52-Week Low: $0.46

Market Sentiment

Purple Biotech currently has a Bearish sentiment score of -0.37.

About Purple Biotech

Purple Biotech Ltd. is a clinical-stage pharmaceutical company based in Rehovot, Israel, dedicated to the development and commercialization of breakthrough therapies for cancer treatment. With a diverse and promising pipeline, the company leverages advanced research techniques to tackle significant unmet needs in oncology, focusing on precision medicine and innovative treatment modalities. As a forward-thinking player in the biopharmaceutical sector, Purple Biotech aims to substantially impro...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Purple Biotech and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PPBT pay dividends?

Purple Biotech (PPBT) does not currently pay a regular dividend.

What is PPBT's market cap?

Purple Biotech (PPBT) has a market capitalization of $6.77M with a current stock price of $0.50.